Chang-lin Yang
Yancheng, 224200, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: February 06, 2023
Abietane diterpenoids from Orthosiphon wulfenioides with NLRP3 inflammasome inhibitory activity.
Journal: Bioorganic chemistry
Published: December 01, 2022
Effect of strategy of control and prevention of intestinal nematodiasis in Dongtai City, Jiangsu Province
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: January 16, 2016
Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.
Journal: Vaccine
Published: May 03, 2015
Endemic situation of malaria in Dongtai City, 1999-2013
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: March 19, 2015
Long-term efficacy of a hepatitis E vaccine.
Journal: The New England journal of medicine
Published: March 05, 2015
Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.
Journal: Human vaccines & immunotherapeutics
Published: October 29, 2013
Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults.
Journal: Human vaccines & immunotherapeutics
Published: July 27, 2013
Surveillance after schistosomiasis transmission interrupted in sandy areas
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: December 15, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026